Searched for
GENE THERAPY TRIAL
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
Scientists just found the holy grail gene that could let humans regrow their own limbs one dayScientists studying naked mole rats discovered a gene linked to high levels of high molecular weight hyaluronic acid (HMW-HA), a substance ...
US FDA approves Novartis' gene therapy for rare muscle disorderThe US FDA has approved Novartis' new gene therapy, Itvisma, which is for patients aged two and above with spinal muscular atrophy. Itvisma...
A cure for type-1 diabetes is within reach: Breakthrough stem cell therapies show promise in 2025Hope is on the horizon for Type-1 diabetes patients. New stem cell therapies are showing remarkable progress. These treatments aim to repla...
What is Huntington's Disease — and what’s the latest breakthrough treatment?Huntington’s disease is a rare, hereditary neurological condition causing progressive neuron loss, movement challenges, cognitive decline, ...
Gene therapy for blood cancer shows 73 per cent response rate in clinical trialsResearchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low and middle-inco...
Driving innovation: India's foray into gene and cell therapiesIndia is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.
CDSCO waives local trials for drugs approved in major marketsThe Central Drugs Standard Control Organisation (CDSCO) has decided to waive local clinical trials for certain drugs approved in select ICH...
British girl's hearing abilities miraculously restored after gene therapyIn an amazing breakthrough in the medical field, using gene therapy by doctors in the UK helped a British girl get her hearing ability back.
Pfizer reports patient death in Duchenne gene therapy studyThe trial is testing boys 2 to three years of age with DMD, a genetic muscle wasting disorder in which most patients lack the protein dystr...
Study says gene therapy for brain tumour shows promise in early resultsA therapy combining cell-killing and immune-stimulating drugs has shown to be safe and effective in extending survival for patients with gl...
Gene therapy can be the answer to brain disorders: StudyScientists are hopeful that disorders like Alzheimer's, Parkinson's, etc. will be treatable in the future.
Immuneel Therapeutics raises $15 million in fundingImmuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...
- CRISPR gene tool can cause unintended flaws in genome
New York, May 30 (IANS) The CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome, warns a new...
How a Bengaluru lab is trying to fix the gene as therapy for hereditary health problemsAs Narayana Nethralaya is fronting it, the focus is on ocular (eye) diseases, though Ghosh’s own area of work is in muscular dystrophy.
Gene editing tool treats muscular dystrophy in adult mammalResearchers from Duke University in US used CRISPR to treat an adult mouse model of Duchenne muscular dystrophy.
- European Commission set to approve first drug based on gene therapy
The idea was conceived in the 1970s but after that, a large number of clinical trials did not result in a commercial drug.